1. Thailand Stocks

  2. •

    Distribution services

  3. •

    Medical distributors
Nice Call Public Company Limited

Nice Call Public Company Limited

0.86
THB
-0.01
(-1.15%)
0.10EPS
9.99P/E
181.67MMarket Cap
Nice Call Public Company Limited
SET:NCP.R
(Stock Exchange of Thailand)

Recent

price

0.86

P/E

ratio

9.99

div

yld

12.82%

ROIC.AI

2022
2023
2024
2025
TTM
THB
1.39
1.33
1.2
1.06
1.03
Revenue per Share
0.16
0.1
0.1
0.12
0.1
Basic EPS, GAAP
-0.17
0.01
-0.02
0.09
-0.22
Free Cash Flow per Basic Share
- -
0.27
0.11
0.12
0.11
Dividend per Share
0.49
0.47
0.99
0.98
0.97
Book Value per Share
0.49
0.46
0.99
0.98
0.97
Tangible Book Value per Share
130
130
152
180
184
Basic Weighted Avg Shares
181
173
182
191
190
Sales/Revenue/Turnover
13.92
8.89
10.02
13.33
11.58
Operating Margin (%)
2
3
5
3
3
Depreciation Expense
20
13
16
21
19
Net Income, GAAP
19.98
19.91
16.96
20.01
19.18
Effective Tax Rate (%)
11.17
7.24
8.57
11.27
9.78
Profit Margin (%)
37
28
93
78
12
Working Capital
- -
- -
1
1
1
LT Debt
88
84
179
177
175
Total Equity
- -
13.85
11.22
11.07
9.77
Return on Invested Capital (%)
- -
14.49
11.82
12.01
10.47
Return on Capital (%)
- -
14.56
11.83
12.06
10.51
Return on Common Equity (%)

Capital Structure

THB

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
- -
- -
1
LT Borrowings
- -
- -
- -
LT Finance Leases
1
1
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
180
180
180
Market Capitalization
160
177
182

Working Capital

THB

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
122
115
63
Cash, Cash Equivalents & STI
107
98
50
Accounts Receivable, Net
5
4
3
Inventories
4
6
6
Total Current Liabilities
44
46
51
Payables & Accruals
43
45
50
ST Debt
- -
- -
1
Deferred Revenue
- -
- -
- -

Growth Rates

THB

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-1.04%
Free Cash Flow
- -
- -
-646.07%
Net Income, GAAP
- -
- -
38.02%
Sales/Revenue/Turnover
- -
- -
4.99%
Total Cash Common Dividend
- -
- -
36.78%

Quarterly Revenue

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
45
43
45
49
182
2025
49
46
46
49
191
2026
48
47
- -
- -
- -

Quarterly Earnings Per Share

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.02
0.03
0.03
0.02
0.1
2025
0.03
0.03
0.03
0.03
0.12
2026
0.02
0.02
- -
- -
- -

Quarterly Dividends Per Share

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.13
- -
- -
0.11
2025
- -
0.07
0.05
0.01
0.12
2026
- -
0.06
- -
- -
- -
Similar Companies
DataMeds AI, Inc. (NASDAQ:MEDS)
Selcuk Ecza Deposu Ticaret ve Sanayi A.S. (BIST:SELEC)
McKesson Corporation (NYSE:MCK)
Ibnsina Pharma (EGX:ISPH)
Cardinal Health, Inc. (NYSE:CAH)
Entero Healthcare Solutions Limited (NSE:ENTERO)
Business
Nice Call Public Company Limited is a Thailand-based direct marketing and customer relationship management company primarily engaged in telesales operations and the distribution of consumer healthcare and personal care products. The company operates through two main business segments: Product Distribution and Contact Center Services. Its core product and service portfolio includes dietary supplements, vitamins, and herbal formulations; skincare, facial care, and body cosmetics; hair care and personal hygiene items; household consumer goods; outbound telesales and direct marketing solutions; inbound customer support and order fulfillment management; and customer database analytics and CRM services. Nice Call markets products under both proprietary house brands and third-party partner brands to consumers across Thailand. Founded in 2014, the company is headquartered in Bangkok, Thailand. In recent developments, Nice Call completed its initial public offering and listed its ordinary shares on the Market for Alternative Investment (mai) under the ticker symbol NCP to fund business expansion, upgrade its contact center IT infrastructure, and expand its telesales workstation capacity. Furthermore, the company has expanded its third-party brand partnerships, integrated AI-driven customer database management tools to optimize call conversion rates, and broadened its product lines to include new health and wellness formulations.